A combination strategy is another approach that has been implemented to treat CF patients that combines drugs that hit multiple targets (such as enhancing CFTR processing and increasing CFTR channel activity), which has led to treatment of the common ΔF508 mutation [168]. This evidence concerns the gene CFTR and cystic fibrosis.